Your browser doesn't support javascript.
loading
Joint Contribution of Genetic Susceptibility and Modifiable Factors to the Progression of Age-Related Macular Degeneration over 10 Years: The Three Continent AMD Consortium Report.
Joachim, Nichole; Kifley, Annette; Colijn, Johanna Maria; Lee, Kristine E; Buitendijk, Gabriëlle H S; Klein, Barbara E K; Myers, Chelsea; Meuer, Stacy M; Tan, Ava G; Flood, Victoria; Schoufour, Josje D; Franco, Oscar H; Holliday, Elizabeth G; Attia, John; Liew, Gerald; Iyengar, Sudha K; de Jong, Paulus T V M; Hofman, Albert; Vingerling, Johannes R; Mitchell, Paul; Klein, Ronald; Klaver, Caroline C W; Wang, Jie Jin.
Afiliación
  • Joachim N; Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Kifley A; Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Colijn JM; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Lee KE; Department of Ophthalmology & Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin.
  • Buitendijk GHS; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Klein BEK; Department of Ophthalmology & Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin.
  • Myers C; Department of Ophthalmology & Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin.
  • Meuer SM; Department of Ophthalmology & Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin.
  • Tan AG; Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Flood V; Faculty of Health Sciences, University of Sydney, Sydney, Australia; Western Sydney Local Health District, Westmead, Australia.
  • Schoufour JD; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Franco OH; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Holliday EG; Centre for Clinical Epidemiology and Biostatistics and School of Medicine and Public Health, University of Newcastle, Newcastle, Australia.
  • Attia J; Centre for Clinical Epidemiology and Biostatistics and School of Medicine and Public Health, University of Newcastle, Newcastle, Australia; Department of Medicine, John Hunter Hospital and Hunter Medical Research Institute, Newcastle, Australia.
  • Liew G; Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Iyengar SK; Department of Epidemiology and Biostatistics, Case Western Reserve University, Cleveland, Ohio.
  • de Jong PTVM; Netherlands Institute of Neurosciences, Institute of the Royal Netherlands Academy of Arts and Sciences, Department of Ophthalmology, Academic Medical Centre, Amsterdam, and Leiden University Medical Centre, Leiden, The Netherlands.
  • Hofman A; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Netherlands Consortium for Healthy Aging, Netherlands Genomics Initiative, The Hague, The Netherlands.
  • Vingerling JR; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Ophthalmology, Radboud University Medical Centre, Nijmegen, The Netherlands.
  • Mitchell P; Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Klein R; Department of Ophthalmology & Visual Sciences, University of Wisconsin Medical School, Madison, Wisconsin.
  • Klaver CCW; Department of Ophthalmology, Erasmus Medical Center, Rotterdam, The Netherlands; Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  • Wang JJ; Centre for Vision Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia; Office of Clinical Sciences and Academic Medicine Research Institute, Duke-NUS, Singapore, Republic of Singapore. Electronic address: jiejin.wang@sydney.edu.au.
Ophthalmol Retina ; 2(7): 684-693, 2018 07.
Article en En | MEDLINE | ID: mdl-31047378
PURPOSE: To assess joint effects of genetic and modifiable factors on the 10-year progression of age-related macular degeneration (AMD). DESIGN: Individual and pooled data analyses of 2 population-based cohorts. PARTICIPANTS: Blue Mountains Eye Study (BMES) and Rotterdam Study (RS) participants (n = 835). METHODS: Participants of the BMES and RS were followed up over 10 years or more. At baseline and follow-up visits, interviews using questionnaires and eye examinations with retinal photography were performed. Age-related macular degeneration was assessed by trained photographic graders and verified by retinal specialists. Genetic susceptibility to AMD meant carrying 2 or more risk alleles of the CFH or ARMS2 SNPs, or both (rs1061170 and rs10490924), relative to 0 or 1 risk allele. Discrete logistic regression models were used to investigate the joint associations of genetic susceptibility and either smoking, fish consumption, dietary intake of lutein-zeaxanthin, or combined environmental risk scores from the 3 modifiable factors with the risk of AMD progression. Odds ratios (ORs) with 95% confidence intervals (CIs) and synergy indexes are reported. MAIN OUTCOME MEASURE: Ten-year progression of AMD, categorized as any (≥1 step) or 2-step (≥2 steps) progression on the Three Continent AMD Consortium 5-step severity scale. RESULTS: Older age, the presence of AMD genetic susceptibility, and baseline AMD status were associated strongly with AMD progression (P < 0.0001). In analyses of pooled data, each additional score from the combined environmental risk scores was associated with an increased risk of 2-step progression over 10 years (OR, 1.26; 95% CI, 1.02-1.56). The copresence of AMD genetic susceptibility and combined risk score of 3 or more was associated with a substantially higher risk of 2-step progression compared with the presence of either factor alone. There was a significant synergistic effect (OR, 4.14; 95% CI, 1.07-15.95) and interaction (P = 0.025) between genetic susceptibility and environmental risk score of 3 or more. CONCLUSIONS: Among persons with AMD genetic susceptibility and pre-existing early AMD lesions, presenting with high environmental risk scores from 3 modifiable factors (smoking, infrequent consumption of fish, low lutein-zeaxanthin intake) were associated with an increased risk of 2-step progression over 10 years.

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ophthalmol Retina Año: 2018 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Prognostic_studies Idioma: En Revista: Ophthalmol Retina Año: 2018 Tipo del documento: Article País de afiliación: Australia Pais de publicación: Estados Unidos